Tag: Oxamniquine

According to the World Health Organization, over 251 million people required preventive treatment for schistosomiasis in 2021. While the disease has been controlled in many regions, the primary pharmacological strategy relies on a limited number of agents. Knowing what are the three drugs used in schistosomiasis provides crucial context for understanding both past and present treatment approaches and the challenges posed by drug resistance.

Globally, more than 200 million people are infected with parasitic flatworms that cause the disease schistosomiasis. Oxamniquine is a medication that was developed to combat this disease and is specifically used to treat infections caused by *Schistosoma mansoni*. Though it has largely been replaced by praziquantel as the first-line treatment, it remains a critical second-line agent, especially in cases where praziquantel is not effective or cannot be tolerated.